What End-Users Think About HIV Prevention Products and Multipurpose Prevention Technologies (MPT)

The Tablets, Ring, Injections as Options study, or TRIO, was conducted with young women aged 18 to 30 in Kisumu, Kenya and Soshanguve, South Africa between 2015 and 2017. The study examined young women’s perspectives on future MPT in a clinical study of three placebo MPT products. TRIO identified anticipated enablers and barriers to adoption and use of future MPT, explored preferred product characteristics, and solicited novel product design recommendations. The project’s key findings and conclusions include that, overall, women desire choice and a diversity of products, and many preferred longer-acting products in familiar forms.
Type: Document
Publication Date: May 21, 2020
Source: The Tablets, Ring, Injections as Options Study (TRIO)